STRW · Strawberry Fields REIT, Inc.
$14.66
+0.06 (+0.41%)
At close · Jul 29
Market Cap
$194.69M
Shares
13.43M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$155M
+32.4%
FY2025
Net Income
$7.58M
+85%
FY2025
Operating Margin
54.38%
+2pp
FY2025
Diluted EPS
$0.60
+5.3%
FY2025
Operating Cash Flow
$90.04M
+51.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| $157.65M | $155MG | $117.06M | $99.81M | $92.54M | $87.03M | |
| $9.07M | $8.61M | $6.85M | $5.66M | $6.01M | $6.3M | |
| — | — | — | $3.03M | $3.03M | $3.03M | |
| — | $46.25M | $33.69M | $29.24M | $28.56M | $27.49M | |
| — | — | — | $2.45M | — | — | |
| $71.43M | $70.71M | $55.76M | $52.37M | $42.6M | $50.27M | |
| $86.22M | $84.29M | $61.3M | $47.44M | $49.95M | $36.76M | |
| — | 54.38% | 52.37% | 47.53% | 53.97% | 42.24% | |
| — | $130.54M | $94.99M | $76.67M | $78.5M | $64.25M | |
| $50.4M | $50.95M | $34.81M | $26.67M | $22.72M | $23.41M | |
| — | -$28K | $10K | -$521K | -$10.81M | -$4.93M | |
| $1.57M | $7.58M | $4.1M | $2.5M | $1.85M | $393K | |
| — | 4.89% | 3.5% | 2.5% | 2% | 0.45% | |
| $27.52M | $25.73M | $22.41M | $17.75M | $14.57M | $3.08M | |
| -$1.27M | -$447K | $3.91M | $2.64M | $4.69M | -$469K | |
| USD/shares | — | $0.60 | $0.57 | $0.39 | $0.31 | $0.07 |
| USD/shares | — | $0.60 | $0.57 | $0.39 | $0.31 | — |
| shares | — | 12.7M | 7.12M | 6.37M | 6.01M | 5.85M |
| shares | — | 12.7M | 7.12M | 6.37M | 6.01M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $3.17M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
22.66×
Peer median 39.85×
Peer medians compare against the 6 similar-size REIT - Healthcare Facilities companies (of 18 listed).